We're going back to patients who were in our earlier trials. There were about 2,000 who participated and we're encouraged that a high percentage of patients have expressed a desire to enroll in this study.

173

Our goal is that we will be able to have public disclosure of all the data and ultimately, we hope to be able to bring it back to patients in need.

84